Unfolded protein response in bronchopulmonary dysplasia: mechanisms, pathways, and therapeutic implications
Frontiers in Cell and Developmental Biology · 23.04.2026 · 14
DOI: 10.3389/fcell.2026.1700811 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 23.04.2026. Verfasst von Haiyue Yu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, The Second Hospital of Jilin University, Changchun, China. Die Arbeit nennt 208 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Jilin Province.
Abstract (Originalsprache)
Bronchopulmonary dysplasia (BPD) is a prevalent chronic lung disease in preterm infants, characterized by impaired alveolarization and abnormal vascular development. Growing evidence indicates that endoplasmic reticulum stress (ERS) and the unfolded protein response (UPR) are closely involved in the pathogenesis of BPD. Under hyperoxic conditions, excessive reactive oxygen species promote protein misfolding and accumulation within the endoplasmic reticulum, leading to activation of the three major UPR branches—IRE1, PERK, and ATF6. Dysregulation of these pathways contributes to lung injury and disrupted development through multiple stress-responsive cellular processes. This review summarizes current understanding of the molecular mechanisms by which UPR signaling participates in hyperoxia-induced lung injury in BPD and discusses therapeutic strategies with potential relevance to UPR modulation, including caffeine, vitamin A, and tauroursodeoxycholic acid (TUDCA), among others, based on available clinical and preclinical evidence. Although some agents have demonstrated clinical benefits in reducing BPD-related outcomes, whether these effects are mediated directly through UPR modulation remains uncertain. In contrast, several UPR-targeting compounds have shown promise in experimental models but lack clinical validation regarding safety and efficacy. Further studies are needed to clarify the cell-type-specific roles of UPR signaling in the developing lung, to better define the transition from adaptive to maladaptive UPR activation, and to support translational efforts that integrate mechanistic insights with clinical investigation. Such advances may help bridge the gap between molecular understanding and therapeutic development for BPD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, The Second Hospital of Jilin University, Changchun, China.
- Department of Critical Care Medicine, The Second Hospital of Jilin University, Changchun, China.
- Department of Neonatology, The Second Hospital of Jilin University, Changchun, China.
- Children Disease Diagnosis and Treatment Center, The Second Hospital of Jilin University, Changchun, China.
Förderung
- Natural Science Foundation of Jilin Province
Zitieren
APA
Yu, H., Guo, Y., Wang, X., Guo, W., & Zhang, Y. (2026). Unfolded protein response in bronchopulmonary dysplasia: mechanisms, pathways, and therapeutic implications. Frontiers in Cell and Developmental Biology, 14. https://doi.org/10.3389/fcell.2026.1700811
Vancouver
Yu H, Guo Y, Wang X, Guo W, Zhang Y. Unfolded protein response in bronchopulmonary dysplasia: mechanisms, pathways, and therapeutic implications. Frontiers in Cell and Developmental Biology. 2026;14. doi:10.3389/fcell.2026.1700811
BibTeX
@article{Yu2026,
author = {Yu, Haiyue and Guo, Yongjing and Wang, Xin and Guo, Wanxu and Zhang, Yunfeng},
title = {Unfolded protein response in bronchopulmonary dysplasia: mechanisms, pathways, and therapeutic implications},
journal = {Frontiers in Cell and Developmental Biology},
year = {2026},
volume = {14},
doi = {10.3389/fcell.2026.1700811}
}
EUVIMED